NEW YORK (GenomeWeb News) - InforSense said today that it has extended and expanded a license agreement with Cambridge University’s Department of Pathology for four of its software platforms.
 
Under the agreement, Cambridge has extended its license for the company’s InforSense and BioSense products, and its GenSense and Genome Wide Association Study modules.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.